Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 1;107(1):35-43.
doi: 10.3324/haematol.2021.278755.

Marginal zone lymphoma: present status and future perspectives

Chan Y Cheah  1 , Emanuele Zucca  2 , Davide Rossi  3 , Thomas M Habermann  4
Affiliations

Marginal zone lymphoma: present status and future perspectives

Chan Y Cheah et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Mechanism of action of selected novel agents for the treatment of marginal zone lymphoma. Bold type indicates approved agents, normal type indicates agents under investigation. IgH: immunoglobulin heavy chain; CD: cluster of differentiation; Syk: spleen tyrosine kinase; Btk: Bruton tyrosine kinase; PLCγ2: phospholipase Cγ2; PKCb: protein kinase Cb; PI3K: phosphatidylinositol-3-kinase; Akt: protein kinase B; bax: B-cell lymphoma-2 associated X protein; Bcl2: B-cell lymphoma protein-2; CAR: chimeric antigen receptor; PD-1, programmed cell death-1. Adapted from Cheah et al. J Clin Oncol 2016.
See this image and copyright information in PMC

References

    1. Reid R, Friedberg JW. Management of marginal zone lymphoma. Oncology (Williston Park). 2013;27(9):840, 842, 844. - PubMed
    1. Sriskandarajah P, Dearden CE. Epidemiology and environmental aspects of marginal zone lymphomas. Best Pract Res Clin Haematol. 2017;30(1-2):84-91. - PubMed
    1. Cerhan JR, Habermann TM. Epidemiology of marginal zone lymphoma. Ann Lymphoma. 2021;5:1. - PMC - PubMed
    1. Swerdlow SH, Campo E, Harris NL, et al. . WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised Fourth Edition. IARC, 2017.
    1. Zucca E, Bertoni F. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood. 2016;127(17):2082-2092. - PubMed

MeSH terms